Paul G. Harch M.D.

Introduction

Hyperbaric oxygen therapy (HBOT) was first defined as a drug in 1977 by Gottlieb (1).

PG Harch, KW Van Meter, SF Gottlieb, P Staab. Jo Ellen Smith Hyperbaric Medicine Unit (JESHMU), New Orleans, LA 70131 and University of South Alabama, Mobile, AL.

Background: We describe a prospective case study of a sport SCUBA diver with Type II DCS (brain) in which HMPAO SPECT brain imaging with oxygen intervention was used in the identification of potentially recoverable brain tissue which subsequently responded to low pressure HOBT as demonstrated by improvement in neurological functions and SPECT brain images.

PG Harch, KW Van Meter, SF Gottlieb, P Staab. JoEllen Smith Hyperbaric Medicine Unit, New Orleans, LA 70131.

Background: No guidelines exist for HBOT tailing treatment of residual neurological injury and no studies document their effect on SPECT brain images and neurological condition in Type II/CAGE DCI as we report herein.

Acute carbon monoxide (CO) poisoning causes brain lipid peroxidation as well as an hypoxic injury. Traditional therapy has been 1 ATA oxygen but now includes hyperbaric oxygen therapy (HBOT) which hastens dissociation of COHgb, reverses anoxia, inhibits reperfusion injury, and has toxic effects. All of these are dose dependant and time sensitive. The human experience with HBOT is anecdotal cases, uncontrolled and controlled series, which are largely positive, and randomized, prospective e controlled studies with conflicting results. A controversy exists over the pressure and number of HBOTs.

Paul G. Harch, Keith Van Meter, Paul K Staab, Sheldon F. Gottlieb, Jo Ellen Smith Medical Center, New Or,sans, LA.
Introduction:

There is no accepted treatment for neurological residual of carbon monoxide poisoning; this report documents the effect of HBOT for established neurological residual.

Methods:

Kevin Barrett, M.D., F.A.C.P. Ð Professor of Hyperbaric Medicine
University of Texas Medical Branch, Galveston, TX, USA

Abstract

Authors: Kevin F. Barrett M.D., Kevan P. Corson CHt, Jon T. Mader, M.D.

Title: Pediatric Cerebral Palsy treated by 1.5 ATA hyperbaric oxygen therapy, a pilot study.

Objective: To determine if 1.5 ATA hyperbaric oxygen therapy can ameliorate the neurologic deficits associated with pediatric cerebral palsy.